Vitamin D Deficiency and Osteoporosis in Rehabilitation Inpatients
Presented to the American Academy of Physical Medicine and Rehabilitation, October 28, 2005, Philadelphia, PA.
Abstract
Shinchuk LM, Morse L, Huancahuari N, Arum S, Chen TC, Holick MF. Vitamin D deficiency and osteoporosis in rehabilitation inpatients.
Objective
To determine vitamin D status and bone mineral density (BMD) in patients admitted to a subacute rehabilitation facility.
Design
Cross-sectional cohort study.
Setting
Subacute rehabilitation facility.
Participants
Fifty-three community-dwelling patients admitted from June through February 2005.
Interventions
Not applicable.
Main Outcome Measures
BMD, 25-hydroxyvitamin D (25[OH]D), C-telopeptide (CTX), osteocalcin, and dietary milk intake.
Results
Prevalence of vitamin D deficiency (25[OH]D <20ng/mL) was 49.1%, while a total of 83% of patients were either vitamin D deficient or insufficient (25[OH]D <30ng/mL). The prevalence of osteopenia (T score, <−1) was 52.8%; osteoporosis (T score, <−2.5) was 17.0%. CTX (bone resorption marker) was elevated in 60.4% of patients. Osteocalcin (bone formation marker) was elevated in 13.2% of patients. Measurements of bone resorption and formation positively correlated (R2=.22) indicating increased bone remodeling.
Conclusions
Vitamin D deficiency and osteopenia and osteoporosis were highly prevalent in patients admitted for rehabilitation. Elevated bone resorption and remodeling were evident. This could be due to vitamin D deficiency that should be corrected before antiresorptive therapy is considered. The study emphasizes the need for vigilance for vitamin D status and BMD testing in patients admitted to rehabilitation facilities.
aDepartment of Physical Medicine and Rehabilitation, Boston University Medical Center, Boston, MA.
bDepartment of Medicine, Boston University Medical Center, Boston, MA.
Correspondence to Michael F. Holick, MD, PhD, Boston University School of Medicine, 715 Albany St, #M1013, Boston, MA 02118.
Supported by the National Institutes of Health (grant no. M01RR 00533).
No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated.